Medtech grants in Canada

Between cycles

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Between cycles

Funds three €5M projects that build earlier, AI-assisted palliative care models for cancer patients and test them in real clinical and home-based settings.

Between cycles

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Between cycles

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Between cycles

Offers early-career deep-tech researchers a free venture-creation and pre-incubation programme with training, coaching and a European bootcamp.

Closed

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Funds AI teams building generative-AI tools for clinical-dataset enhancement or automotive crash-test case generation, paying up to €100,000 in prizes after an initial €28,500 concept-stage award.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Closed

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Funds international biotech R&D consortia through each country's own national funding scheme.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.

Closed

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Closed

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Closed

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Closed

Funds public-private research that connects fragmented health R&I efforts into shared tools, data, platforms and manufacturing processes.

Closed

Funds public-private research on interoperable health data and AI analytics that speed up diagnosis, treatment and personalised care.

Closed

Funds three lead projects, worth up to EUR 15 million each, that each run a multi-stage generative-AI competition in aerospace, pharma or telecom — with EUR 250,000 grants to the top 20 entrants and EUR 2 million grants to the final four.

Closed

Funds research and low-carbon medical technology that cuts the health sector's own emissions while making healthcare systems and communities more resilient to climate change.

Closed

Funds one consortium to build a scannable digital-label standard that replaces cluttered printed labelling on medical devices and diagnostics.

Closed

Funds one coordination project that pilots a digital, data-driven replacement for the paper-heavy conformity assessment process device makers use to get CE marking under the MDR and IVDR.

Closed

Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.

Closed

Awards EU deep-tech teams up to €2.5 million in lump-sum grants across two stages.